Streetbeat News

Price Targets

PDD

A whale investor has taken a bullish stance on PDD Holdings (NASDAQ:PDD), with 50% of detected trades being bullish and 50% bearish. Whales have targeted a price range of $50 to $105 for PDD Holdings over the last 3 months. Goldman Sachs downgraded PDD to Neutral with a price target of $93, while Citigroup maintained a Buy rating with a price target of $100.

Portfolio Pulse from Benzinga Insights

May 19, 2023 | 2:30 pm

CRMD

CorMedix shares are trading higher after JMP Securities maintained an Outperform rating on the stock and raised its price target from $16 to $19.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 2:16 pm

NDLS

Noodles & Company shares dropped after the announcement of CFO Carl Lukach's departure and a downgrade by Stephens & Co from Overweight to Equal-Weight, with a reduced price target from $7 to $5.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 2:12 pm

LEGN

Legend Biotech's stock is trading higher after multiple analysts increased their price targets on the company.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 2:10 pm

CHRD

Over the past 3 months, 12 analysts have published their opinion on Chord Energy (NASDAQ:CHRD) stock, with 7 bullish and 5 somewhat bullish ratings. The average 12-month price target for CHRD is $206.33, with a high of $252.00 and a low of $172.00. The average price target has increased by 1.24% over the past month.

Portfolio Pulse from Benzinga Insights

May 19, 2023 | 2:07 pm

ZG

Over the past 3 months, 10 analysts have published their opinion on Zillow Gr (NASDAQ:ZG) stock, with an average 12-month price target of $49.2, up 9.82% from the previous average of $44.80.

Portfolio Pulse from Benzinga Insights

May 19, 2023 | 2:04 pm

NFLX

A whale investor has taken a bearish stance on Netflix (NASDAQ:NFLX), with 60% of detected trades being bearish and 40% bullish. Whales have been targeting a price range of $350 to $380 for Netflix over the last 3 months. Wedbush downgraded its action to Outperform with a price target of $410.

Portfolio Pulse from Benzinga Insights

May 19, 2023 | 2:04 pm

BEAT

Benchmark analyst Bill Sutherland reiterates a Speculative Buy rating on HeartBeam (NASDAQ:BEAT) and maintains an $8 price target.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 1:34 pm

EBS

Benchmark analyst Robert Wasserman reiterates a Buy rating on Emergent BioSolutions (NYSE:EBS) and maintains a $22 price target.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 1:33 pm

GRAB

Benchmark analyst Fawne Jiang reiterates a Buy rating on Grab Holdings (NASDAQ:GRAB) and maintains a $4 price target.

Portfolio Pulse from richadhand@benzinga.com

May 19, 2023 | 1:32 pm